ClinicalTrials.Veeva

Menu

Quality of Life of Patients With Locally Advanced and Metastatic Prostate Cancer (PROS-PROSQoLI)

Ipsen logo

Ipsen

Status

Completed

Conditions

Prostate Cancer

Study type

Observational

Funder types

Industry

Identifiers

NCT02853409
A-92-52014-215

Details and patient eligibility

About

The purpose of this study is to evaluate possible changes in quality of life related to health (HRQL) in locally advanced and metastatic prostate cancer patients, after one year of follow-up.

Enrollment

628 patients

Sex

Male

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Men ≥ 18 years old
  • Symptomatic prostate cancer patients who present symptoms due to prostate cancer disease
  • Capacity to comply with the protocol
  • Patient with an expected survival > 12 months

Exclusion criteria

  • Patients who are also participating in any other clinical study
  • Patient with other malignant diseases, apart from prostate cancer

Trial contacts and locations

14

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems